There's a certain irony in using one of Earth's most abundant elements—silicon—to solve one of the battery industry's most stubborn problems. Yet that's precisely what AmpliSi, a spin-out from the University of Sheffield incorporated in August 2025, believes it can pull off.
The company secured £2 million in pre-seed funding this March, co-led by Northern Gritstone and Clean Growth Fund. For Clean Growth Fund, the deal represents something of a coming-out party: AmpliSi is the first investment from the firm's newly launched Fund II, which recently closed its initial tranche at £49 million. Northern Gritstone, meanwhile, has been nurturing the company through its NG Studios venture-building program.
What AmpliSi is chasing isn't incremental improvement. It's pitching a wholesale replacement for graphite, the carbon-based material that has dominated lithium-ion battery anodes since the technology's commercial inception. The Sheffield team's alternative? Porous silicon manufactured through what the company describes as a proprietary, silane-free, low-temperature magnesiothermic process—industry jargon for a chemical conversion that turns common silica into battery-grade silicon at temperatures below 400°C.
According to the company, the material delivers up to four times the energy density of conventional graphite anodes, with a 30 percent reduction in cost per kilowatt-hour. Those are bold claims from the company, and they haven't been independently verified. But they're compelling enough to have attracted institutional capital at a moment when battery supply chains have become a matter of geopolitical anxiety.
Beyond Performance Metrics
Clean Growth Fund's investment thesis, laid out in a March 18 commentary, makes the strategic calculation explicit. China's near-monopoly on graphite production and processing represents a critical vulnerability—one that European and UK policymakers have increasingly flagged as battery demand accelerates. AmpliSi, in this framing, isn't just a better mousetrap. It's a potential pathway toward what industrial strategists now call "sovereign manufacturing capability."
Whether a Sheffield-based startup with a handful of employees can genuinely reshape global battery supply chains remains, of course, an open question. But the framing reveals how dramatically the conversation around deep tech investment has shifted. Performance matters; so does provenance.
Dr. Ruth Sayers, AmpliSi's CEO, comes to the role with notable credentials. She spent over fourteen years in battery commercialization, most recently as Director of Technology at Faradion, the UK sodium-ion battery developer acquired by India's Reliance Industries in late 2021. That exit—one of the more significant British battery deals in recent memory—lends her a certain credibility in an industry where academic founders sometimes struggle to bridge the lab-to-market chasm.
Her co-founder, Dr. Gwen Chimonides, serves as CTO while maintaining her position as a Research Associate at Sheffield. Professor Siddharth Patwardhan, whose laboratory developed much of the underlying science, has taken on the role of Chief Scientific Advisor. The technology itself traces back to a 2022 Faraday Institution seed project focused on scalable silicon anode manufacturing—suggesting the team has been refining this approach for several years before incorporation last August.
The Scale-Up Challenge
The £2 million will fund what investors describe as a transition from proof-of-concept toward industrial scale-up and early customer engagement. As of mid-2026, AmpliSi employed somewhere between two and ten people—precise headcount figures haven't been disclosed—and the company has yet to publicly name any cell manufacturers or automotive OEMs as partners, though investor materials reference plans for customer pilots.
That's standard for a pre-seed company, though it underscores the distance between laboratory validation and commercial traction. Battery manufacturers are notoriously conservative, for good reason: a single materials defect in a mass-produced cell can cascade into recalls, fires, or catastrophic brand damage. Convincing a tier-one player to trial a novel anode material requires more than promising PowerPoint slides.
Northern Gritstone's Gareth Llewellyn and Clean Growth Fund's Stephen Price both joined AmpliSi's board as investment directors on March 4, a routine governance arrangement for institutional backers at this stage. The company filed its first accounts in June, covering the period ending March 31—a slim document that, as is typical for a business barely out of incorporation, offers more questions than answers.
Perhaps the most revealing detail is what hasn't been said. AmpliSi hasn't disclosed production timelines, pilot-scale facility plans, or partnership discussions in any specificity. That reticence might reflect competitive concerns, or it might simply reflect how early-stage this venture remains.
For now, the company faces a challenge that's straightforward to articulate if devilishly complex to execute: proving that a university lab process can scale to commercial volumes while delivering on its performance and cost claims in the unforgiving environment of real-world battery manufacturing. Silicon anodes have tantalized researchers for years, promising energy densities that graphite simply cannot match. But silicon also swells and contracts dramatically during charge-discharge cycles, a phenomenon that has bedeviled commercialization efforts for decades.
Whether AmpliSi's porous architecture solves that problem—or merely postpones it—will determine whether this £2 million bet becomes a footnote or a breakthrough. The answer, as with most deep tech ventures, won't arrive quickly.
